Avanos Medical (AVNS) Other Non-Current Liabilities (2013 - 2026)

Avanos Medical has disclosed Other Non-Current Liabilities across 14 years of filings, most recently posting $14.1 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 213.33% year-over-year to $14.1 million; the TTM figure through Mar 2026 stood at $14.1 million (up 213.33% YoY), while the FY2025 annual figure was $13.5 million, up 206.82% from the prior year.
• Other Non-Current Liabilities came in at $14.1 million for Q1 2026 at Avanos Medical, up from $13.5 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $28.0 million in Q1 2022 to a low of $4.3 million in Q2 2025.
• Average Other Non-Current Liabilities over 5 years is $14.9 million, with a median of $14.1 million recorded in 2026.
• Year-over-year, Other Non-Current Liabilities slumped 59.05% in 2025 and surged 213.33% in 2026.
• Over 5 years, Other Non-Current Liabilities stood at $20.5 million in 2022, then plunged by 51.22% to $10.0 million in 2023, then sank by 56.0% to $4.4 million in 2024, then jumped by 206.82% to $13.5 million in 2025, then advanced by 4.44% to $14.1 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $14.1 million in Q1 2026, $13.5 million in Q4 2025, and $20.7 million in Q3 2025.